南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

一种靶向USP8的纳米放大器与放射治疗协同作用,重塑肺癌免疫抑制型肿瘤微环境

A USP8-Targeting Nanoamplifier Synergizes with Radiotherapy to Remodel the Immunosuppressive Tumor Microenvironment in Lung Cancer

Junjian Deng, Peiyi Luo, Kejun Li, Miaomiao Zhang, Ruxin Zhang, Zengxing Zhang, Songlin Wang, Yongfa Zheng

Journal:Materials Today Bio

IF:11

DOI:10.1016/j.mtbio.2026.103631

PMID:42828104

Published:2026-09-04

research field:肿瘤微环境肿瘤免疫学药理学免疫治疗微生物学信号转导代谢物发现

Abstract

Radiotherapy (RT) remains a cornerstone in lung cancer treatment, but its efficacy is often limited by radioresistance and an immunosuppressive tumor microenvironment (TME). Here, we identify the deubiquitinating enzyme USP8 as a key regulator of M2-like tumor-associated macrophages (TAMs) in the irradiated TME. To exploit this finding, we developed a biomimetic nanoparticle, USP8@CPMOF, which co-delivers a USP8 inhibitor and an anti-PD-L1 nanobody-coated membrane. This nanosystem specifically targets both irradiated tumor cells and TAMs, responding to the acidic and high-glutathione TME to trigger ferroptosis and release the USP8 inhibitor. In vitro , USP8@CPMOF enhanced RT-induced apoptosis and ferroptosis, promoted dendritic cell maturation, and reprogrammed M2 macrophages toward an M1 phenotype. In vivo , it improved tumor accumulation, synergized with RT to suppress tumor growth and metastasis, and robustly remodeled the TME by increasing cytotoxic T cell infiltration and reducing immunosuppressive cells. This work presents a promising nanomedicine strategy to overcome radioresistance by simultaneously targeting tumor cells and the immunosuppressive TME.

本文使用的Yeasen产品

购物车
客服
转染试用